1. Home
  2. ARAY vs BEAT Comparison

ARAY vs BEAT Comparison

Compare ARAY & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Accuray Incorporated

ARAY

Accuray Incorporated

HOLD

Current Price

$0.25

Market Cap

31.3M

Sector

Health Care

ML Signal

HOLD

Logo Heartbeam Inc.

BEAT

Heartbeam Inc.

HOLD

Current Price

$0.41

Market Cap

27.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARAY
BEAT
Founded
1990
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
31.3M
27.7M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
ARAY
BEAT
Price
$0.25
$0.41
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$3.50
$5.63
AVG Volume (30 Days)
497.6K
299.1K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
87.50
15.07
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.58
$315.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.39
52 Week High
$2.10
$4.00

Technical Indicators

Market Signals
Indicator
ARAY
BEAT
Relative Strength Index (RSI) 40.39 30.76
Support Level $0.23 N/A
Resistance Level $0.33 $0.52
Average True Range (ATR) 0.02 0.03
MACD -0.00 -0.00
Stochastic Oscillator 12.33 8.81

Price Performance

Historical Comparison
ARAY
BEAT

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.

About BEAT Heartbeam Inc.

HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.

Share on Social Networks: